Watson Pharmaceuticals

bone.jpgIPNews® – The Federal Circuit on Thursday shot down Hoffmann-La Roche Inc.’s appeal of a district court’s refusal to grant it a patent injunction stopping three generic drug makers from producing their own versions of Roche’s osteoporosis drug Boniva.

Roche could not prove it was likely to overcome Apotex Inc., Watson Pharmaceuticals Inc. and Mylan

pills.jpgIPNews® – A U.S. District Court in Delaware recently ruled that Allergan’s patents related to its Sanctura XR drug are invalid. 

The ruling stems from a 2009 patent infringement complaint filed by Allergan against Watson Pharmaceuticals, in its attempts to prevent Watson from filing an abbreviated new drug application with the FDA for the generic